Evidence map›Paper›PMID 37338211›Full record

ArticlemSphere2023

Longitudinal and quantitative fecal shedding dynamics of SARS-CoV-2, pepper mild mottle virus, and crAssphage.

Peter J Arts, J Daniel Kelly, Claire M Midgley, Khamal Anglin, Scott Lu, Glen R Abedi, Raul Andino, Kevin M Bakker, Bryon Banman, Alexandria B Boehm and 13 more

Abstract read
In one paragraph

Article in mSphere, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Real-time, multi-pathogen wastewater genomic surveillance with Freyja 2.medRxiv : the preprint server for health sciences · 2025
    Article
  9. Dynamics of SARS-CoV-2 variants in southwest Ohio municipal wastewater.Environmental science : water research & technology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Peter J ArtsDepartment of Civil and Environmental Engineering, University of Michigan , Ann Arbor, Michigan, USA.ORCID 0000-0002-6002-0906
J Daniel KellyDepartment of Epidemiology and Biostatistics, University of California , San Francisco, California, USA.
Claire M MidgleyNational Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia, USA.
Khamal AnglinDepartment of Epidemiology and Biostatistics, University of California , San Francisco, California, USA.
Scott LuDepartment of Epidemiology and Biostatistics, University of California , San Francisco, California, USA.
Glen R AbediNational Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia, USA.
Raul AndinoDepartment of Microbiology and Immunology, UCSF , San Francisco, California, USA.
Kevin M BakkerDepartment of Epidemiology, University of Michigan , Ann Arbor, Michigan, USA.
Bryon BanmanDepartment of Civil and Environmental Engineering, University of Michigan , Ann Arbor, Michigan, USA.
Alexandria B BoehmDepartment of Civil & Environmental Engineering, Stanford University , Stanford, California, USA.ORCID 0000-0002-8162-5090
Melissa Briggs-HagenNational Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia, USA.
Andrew F BrouwerDepartment of Epidemiology, University of Michigan , Ann Arbor, Michigan, USA.
Michelle C DavidsonSchool of Medicine, University of California , San Francisco, California, USA.
Marisa C EisenbergDepartment of Epidemiology, University of Michigan , Ann Arbor, Michigan, USA.
Miguel Garcia-KnightDepartment of Microbiology and Immunology, UCSF , San Francisco, California, USA.
Sterling KnightDepartment of Civil and Environmental Engineering, University of Michigan , Ann Arbor, Michigan, USA.
Michael J PelusoDivision of HIV, Infectious Disease, and Global Medicine, UCSF , San Francisco, California, USA.
Jesus Pineda-RamirezDepartment of Epidemiology and Biostatistics, University of California , San Francisco, California, USA.
Ruth Diaz SanchezDepartment of Epidemiology and Biostatistics, University of California , San Francisco, California, USA.
Sharon SaydahNational Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia, USA.
Michel TassettoDepartment of Microbiology and Immunology, UCSF , San Francisco, California, USA.
Jeffrey N MartinDepartment of Epidemiology and Biostatistics, University of California , San Francisco, California, USA.
Krista R WiggintonDepartment of Civil and Environmental Engineering, University of Michigan , Ann Arbor, Michigan, USA.ORCID 0000-0001-6665-5112

Funding

Characterizing the virologic and immunologic signatures of HIV exceptional controlK23AI157875 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PELUSO, MICHAEL JOSEPH · 2021 to 2025
$927k
Understanding the epidemiology and natural history of unrecognized Ebola virus infectionK23AI146268 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KELLY, JOHN DANIEL · 2019 to 2022
$748k
NIAID NIH HHS K23 AI146268NIAID NIH HHS K23 AI157875NIAID NIH HHS L30 AI126521NIAID NIH HHS L30 AI147159
6 · The paper itself

Abstract

Wastewater-based epidemiology (WBE) emerged during the coronavirus disease 2019 (COVID-19) pandemic as a scalable and broadly applicable method for community-level monitoring of infectious disease burden. The lack of high-resolution fecal shedding data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) limits our ability to link WBE measurements to disease burden. In this study, we present longitudinal, quantitative fecal shedding data for SARS-CoV-2 RNA, as well as for the commonly used fecal indicators pepper mild mottle virus (PMMoV) RNA and crAss-like phage (crAssphage) DNA. The shedding trajectories from 48 SARS-CoV-2-infected individuals suggest a highly individualized, dynamic course of SARS-CoV-2 RNA fecal shedding. Of the individuals that provided at least three stool samples spanning more than 14 days, 77% had one or more samples that tested positive for SARS-CoV-2 RNA. We detected PMMoV RNA in at least one sample from all individuals and in 96% (352/367) of samples overall. CrAssphage DNA was detected in at least one sample from 80% (38/48) of individuals and was detected in 48% (179/371) of all samples. The geometric mean concentrations of PMMoV and crAssphage in stool across all individuals were 8.7 × 10

Indexed as

COVID-19TobamovirusHumansRNA, ViralSARS-CoV-2RNA, ViralcrAssphagefecal sheddingPMMoVSARS-CoV-2stool

Identifiers

PMID37338211
PMCPMC10506459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.